icon-    folder.gif   Conference Reports for NATAP  
 
  AIDS 2022
July 29 - Aug 2
24th Intl AIDS Conference
Back cgrey_arrow_rt.gif
 
 
 
Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humans
 
 
  AIDS 2022 July 29-Aug 2 Montreal
 
Randolph P. Matthews,1 Kerry L. Fillgrove,1 Munjal Patel,1 Wen Liu,1 Catherine Z. Matthews,1 Yang Liu,1 Irene Mirkin,2 S. Aubrey Stoch,1 Marian Iwamoto1 1Merck & Co., Inc., Rahway, NJ, USA; 2Labcorp Clinical Research Unit, Madison, WI, USA

0807221copy

0807222copy

0807223copy

0807224copy

0807225copy

0807226copy